Search research articles
Contact Us
Filters
Showing results (391-400 of 433) with videos related to
Page
of 44
Sort By:
Cell
|
May 12, 2023
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases
Matae Ahn, Vivian Chih-Wei Chen, Pritisha Rozario, et al.
Emerging Microbes & Infections
|
September 6, 2023
Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor
Meisam Yousefi, Wai Suet Lee, Wharton O Y Chan, et al.
Nature Microbiology
|
October 4, 2022
SARS-CoV-2 Omicron variant emerged under immune selection
Chee Wah Tan, Wan Ni Chia, Feng Zhu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 2, 2021
Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
Nguyen Van Vinh Chau, Le Nguyen Thanh Nhan, Lam Anh Nguyet, et al.
Mbio
|
July 23, 2020
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2
Yvonne C F Su, Danielle E Anderson, Barnaby E Young, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humans
Jonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
Singapore Medical Journal
|
April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learnt
Jun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
The Lancet. Infectious Diseases
|
July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29
Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
NPJ Vaccines
|
January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Page
of 44
Search research articles
Search
Showing results (391-400 of 433) with videos related to
Sort By:
Page
of 44
Cell
|
May 12, 2023
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases
Matae Ahn, Vivian Chih-Wei Chen, Pritisha Rozario, et al.
Emerging Microbes & Infections
|
September 6, 2023
Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor
Meisam Yousefi, Wai Suet Lee, Wharton O Y Chan, et al.
Nature Microbiology
|
October 4, 2022
SARS-CoV-2 Omicron variant emerged under immune selection
Chee Wah Tan, Wan Ni Chia, Feng Zhu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 2, 2021
Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
Nguyen Van Vinh Chau, Le Nguyen Thanh Nhan, Lam Anh Nguyet, et al.
Mbio
|
July 23, 2020
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2
Yvonne C F Su, Danielle E Anderson, Barnaby E Young, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humans
Jonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
Singapore Medical Journal
|
April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learnt
Jun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
The Lancet. Infectious Diseases
|
July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29
Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
NPJ Vaccines
|
January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Page
of 44